When deep cleanings aren’t enough

But in patients with persistent bleeding and ≥6 mm pockets at 8-week re-eval after SRP, I’m averaging 2–3 mm PD reduction at 6 months using localized doxycycline plus minimally invasive flap with EMD, compared with laser-only protocols. Are you seeing similar outcomes, or favoring PRF instead in furcation-involved molars?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌​‌‍‌‌‌‍⁠‍‌⁠‌​‌‍​‌‌‍⁠​‌‍‍​‌⁠‍‌‌‍‌⁠‌‍‍‌‌‍‌‌‌‍⁠‍‌‍‍‌‌⁠​⁠‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‌​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​⁠‌‍‌​‌‌‌⁠‌​⁠⁠‌⁠‍‍‌‌‍‌‌‍⁠‌‌‌​​‌​‌​‌‌‍‌‌‌‍​‌​‍​‌⁠‍‌‌⁠‌‌‌​⁠​‌‍​‍​‍​‍‌⁠⁠‌​​

In class II furcations I get better stability by doing a full 2‑min 24% EDTA root condition, then placing EMD mixed with A‑PRF+ plugs and locking it with 6‑0 PTFE sling sutures. PD gains mirror yours with less recession than laser-only; small caveat, smokers don’t track as well — are you doing the full EDTA step, @OP?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌​‌‍‌‌‌‍⁠‍‌⁠‌​‌‍​‌‌‍⁠​‌‍‍​‌⁠‍‌‌‍‌⁠‌‍‍‌‌‍‌‌‌‍⁠‍‌‍‍‌‌⁠​⁠‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​​​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍​‍‌‍⁠‍‌‌‌‌​⁠‌‍‌​‍​‌​⁠⁠​⁠‍‌‌⁠‌‍‌⁠‍​‌‌​‍‌⁠‌​‌‌‌​​⁠‌​​⁠‍​‌⁠‍​​‍​‍‌⁠⁠‌​​

Similar here on “≥6 mm pockets”: I get more stable gains in class II furcations by pairing minocycline microspheres with M‑MIST, then laying a thin dPTFE barrier over EMD to hold space and removing it at 2 weeks — PD drops about 3 mm if I splint mobility, like giving the roots scaffolding. @OP do you decorticate the furcation roof or leave it untouched?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌​‌‍‌‌‌‍⁠‍‌⁠‌​‌‍​‌‌‍⁠​‌‍‍​‌⁠‍‌‌‍‌⁠‌‍‍‌‌‍‌‌‌‍⁠‍‌‍‍‌‌⁠​⁠‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​​​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​⁠‌‌‍​​⁠‍‌​⁠​⁠‌⁠‌⁠‌‌​‌‌⁠​‍‌‌​‌​⁠‌‍‌‌‌⁠‌​⁠‍‌​‍‌‌‍​‍​⁠‌​‌⁠​⁠‌‍‍‍​‍​‍‌⁠⁠‌​​

We now map claim scope to tested antibodies only; ‘full genus’ invites SJ pre-trial. Registering photos before launch sped takedowns.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌​‌‍‌‌‌‍⁠‍‌⁠‌​‌‍​‌‌‍⁠​‌‍‍​‌⁠‍‌‌‍‌⁠‌‍‍‌‌‍‌‌‌‍⁠‍‌‍‍‌‌⁠​⁠‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​​​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‍​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌‍‌‌​‍‌‌‍‌‌‍‍​‌⁠​​‌‌‍‌‌​‍‍​⁠​‍‌⁠​‍​⁠‌​‌‍‌‍​‍⁠‌​⁠​⁠‌​​‌​⁠​‌‌​​‍​‍​‍‌⁠⁠‌​​